| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c9b3a4deb69dff99baa984dc96b7748d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_04fa9a50a77d6a3d92c9c54f4533165f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84bbd0b1062cc7ed1acf530b9d9536fe |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2011-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21e637e6e8bb9493cc6126300a60fb43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_881d6d1131f3603d89e89fcf6426ec11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8c75d2335a8120105052af8217b90a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d488aa6dcf4ca85ed7e668f45df8e194 |
| publicationDate |
2012-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2505663-A1 |
| titleOfInvention |
A method to identify asymptomatic high-risk individuals with early stage lung cancer by means of detecting miRNAs in biologic fluids |
| abstract |
A diagnostic and/or prognostic model of at least 5 serum miRNAs selected among a group of 34 miRNAs that identifies subjects with early stage lung cancer, namely non-small cell lung carcinomas (NSCLCs), in a population of asymptomatic high-risk individuals, with 80% accuracy. The model could also distinguish between benign and malignant lesions and is sensitive enough to capture the disease onset. In addition, the model could also diagnose or confirm a diagnosis of lung cancer in symptomatic patients, and monitor the lung tumor status after treatment with surgery and/or chemotherapy and/or radiotherapy in a subject with such lung cancer. |
| priorityDate |
2011-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |